BPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2023 in the Senate and the U.S. House of Representatives (H.R. 1472). BPIA thanks Senators Mike Braun (R-IN) and Alex Padilla (D-CA) as well as Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) for sponsoring the bill.

BPIA and other industry stakeholders suggested the PMRA consider reviewing and modernizing regulations for dual property products containing crop protection and crop health improvement properties to enable registration of these products under single label.

BPIA hosted a virtual listening session regarding biostimulants to support the National Biotechnology and Biomanufacturing Initiative.

BPIA provided input to the White House Office of Science and Technology Policy regarding the Coordinated Framework to accelerate biotechnology innovation and grow America’s bioeconomy.

BPIA provided a response to the PMRA’s request for comments regarding PRO2022-01 Pre-Consultation – Proposed Regulatory Amendments to the Pest Control Products Regulations

BPIA filed comments regarding ANPR concerning USDA-AMS-NOP’s request for comments on how to rectify the USDA organic regulations’ references to outdated EPA policy on inert ingredients used in pesticide products.

BPIA applauds the reauthorization of the Pesticide Registration Improvement Act. PRIA 5 provides necessary resources to EPA’s Office of Pesticide Programs including the Biopesticides and Pollution Prevention Division.

BPIA provided comments on the Natural Resources Conservation Service Request for Information on the implementation of the Inflation Reduction Act funding.

The Journal of Regulatory Science publishes the United States Biostimulant Industry Recommended Guidelines to Assess Efficacy, Composition, and Safety of Plant Biostimulant Products.

BPIA joins research effort focused on learning more at field-level about biological products.

Congressman Jimmy Panetta discussed the Plant Biostimulant Act during a House Ag Committee hearing on soil health practices.

BPIA and FACA commend the U.S. Department of Agriculture for its consideration and selection of pilot projects through its Partnerships for Climate-Smart Commodities.

BPIA provided comments regarding the USDA’s Animal and Plant Health Inspection Service’s Strategic Plan Framework,

Making Sense of Biologicals, a series from AgNet West that dives into various topics with unbiased experts in the field of biologics, talked with BPIA.

BPIA hosted its biggest annual meeting ever in Monterey, California.

BPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2022 and thanks Congressman Jimmy Panetta (D-CA) and Congressman Jim Baird (R-IN) for sponsoring the bill.

The United States Biostimulant Industry Completes Recommended Guidelines to Support Efficacy, Composition, and Safety of Plant Biostimulant Products